Introduction: Biomarker computation using deep-learning often relies on a two-step process, where the deep learning algorithm segments the region of interest and then the biomarker is measured. We propose an alternative paradigm, where the biomarker is estimated directly using a regression network. We showcase this image-tobiomarker paradigm using two biomarkers: the estimation of bone mineral density (BMD) and the estimation of lung percentage of emphysema from CT scans.
INTRODUCTION
Deep learning has been used extensively in medical image analysis, 1 replacing all previously known classifiers in applications that include those related to computer-aided detection, 2, 3 image segmentation 4, 5 and registration, 6 in modalities ranging from calcium scoring in CT images 7 to the analysis of histopathology slides 8 or even diagnosis 9, 10 and prognosis.
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We propose deep learning biomarker estimation method based on a regression network where we input to algorithm images containing the structure where the biomarker is computed and output directly the biomarker value. The two chosen biomarkers to showcase the proposed regression architecture are bone mineral density (BMD) and emphysema, which are relevant to the medical community.
Osteoporosis is a common disease characterized by the loss of bone tissue, resulting in fractures that impact substantially health care costs, morbidity and mortality. Osteoporosis impact especially in regions with aging
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Max-Pooling populations, such as Europe, 12 and the United States, with more than 10.2 estimated subjects. 13 Osteoporotic fractures due to low bone mineral density (BMD) have been increasing in the last decades.
14 Early detection of osteoporosis may prevent such fractures and lower the burden of this disease, 13 since cost-effective therapeutic possibilities exist. 15 However, low BMD remains undiagnosed in the general population. 16 BMD estimated thoracic CT scans have been shown to correlate significantly with BMD estimated on lumbar vertebrae, 17 and has been suggested as a screening tool for smokers. 18 To our knowledge, no study has yet evaluated the performance of a deep learning method for BMD estimation.
Emphysema is a lung disease that gradually damages the alveoli, impeding their proper functioning and reducing the lung capacity of the subject. 19 Emphysema is one of the leading causes of chronic obstructive pulmonary disease (COPD), which is responsible for significant costs to health systems and is now the third leading cause of death. 20 Emphysema has been traditionally quantified as the percentage of lung volume below a given threshold. This method has shown to correlate well with histopathology 21 and has become the de-facto standard for emphysema quantification that is currently adopted as end-points in clinical trials.
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In this paper, we automate the measurement of BMD and emphysema in Chest CT scans using the deep convolutional neural network of Fig. 1 . Such network inputs axial, coronal and sagittal reformatted images and outputs the biomarkers directly, without a prior segmentation or identification structures of interest. We use a large cohort consisting of 10, 000 CT scans from the COPDGene study 23 to train, validate and test the proposed method.
METHODS

Database
The COPDGene multi-center observational study has acquired CT scans of non-hispanic Caucasian and African American individuals with a history of at least 10 pack-years of smoking. 23 Images were acquired with a multidetector CT scanner with at least 16 detector channels. 9925 images of different subjects were used for this study. Each volumetric image is reconstructed with sub-millimeter slice thickness. 7,925 cases of the database are used for training the network, 1,000 cases are used for validation of the training and the selection of the network's meta-parameters and the final 1,000 cases of the dataset are used for testing, and used only once. We report the results of those 1,000 testing cases.
The reference standard for BMD is generated using the semi-automated N-Vivo software (Image Analysis Inc., Columbia, KY). Manual quality control was performed to exclude fractured vertebrae. The lung parenchyma was segmented in 3D, and the percentage of lung voxels below a given threshold were reported as being emphysema and computed using the Chest Imaging Platform (chestimagingplatform.org).
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Image pre-processing
Each volumetric image is processed with an object detector trained to detect relevant structures for the biomarker that is going to be predicted. The object detector is described in 24 and adapted for the relevant structures. For BMD estimation, we detect the position of the spine in coronal and sagittal planes and generate a composite image similar to those of the top row of Fig. 2 . For the estimation of the percentage of emphysema we select an axial slice where the whole heart is visible, two sagittal slices at the level of the right and left hila and a coronal slice at the level of the ascending aorta, making composite images of those four views, as shown in the bottom row of Fig. 2 . This image pre-processing is necessary due memory and processing power constraints of current GPUs. Each image is clamped to the range [−1024, 1500] prior to re-scaling to the range [0, 1].
Deep Learning Architecture and Training Strategy
We use the deep learning network of Fig. 1 to estimate the biomarkers from the images mentioned above. The neural network consists of three convolutional layers followed by rectified linear activations and max-pooling operations and two fully-connected layers with also rectified linear activations, except the output layer. Filter size is set to 5 pixels. We place dropout layers prior to each fully connected layer to prevent overfitting. We set their dropout percentage to 50%. The network is optimized using a momentum optimizer with a learning rate that decays exponentially with the number of iterations. The cost function optimized is the root mean squared error. The parameters of the optimizer are chosen using the validation cases. We train for 10 epochs. The code is implemented using the TensorFlow library. 
Statistical Analysis
We estimate the linearity of the output of the network to the reference standard using the Pearson correlation coefficient. To compare agreement among methods, we use Bland-Altman analysis. Statistical analysis is made using MedCalc software (MedCalc Software Bvba, Osten, Belgium).
RESULTS
Bone Mineral Density
The predicted BMD showed a correlation coefficient of ρ = 0.940; 95%; CI = [0.933 − 0.947]; p < 1e − 4 with the reference standard on the 1000 test cases. 
Percentage of Emphysema
The We transformed the percentage emphysema measurements to log-scale in order to perform further statistical analysis, since most of the cases are centered around 5 percent units. There correlation coefficient in log-scale between the proposed method and the reference standard is ρ = 0.938; 95%; CI = [0.930 − 0.945]; p < 1e − 4, as shown in Fig. 4 . In log-scale, the mean difference is 0.002, the standard deviation of the difference is 0. 
DISCUSSION
In this paper, we have proposed the use of deep learning for biomarker quantification directly from 2D images obtained from 3D CT scans, without the prior segmentation of structures of interest. We have achieved strong correlations against reference standards for two use cases: the estimation of BMD measured on vertebrae in the spine (ρ = 0.940; p < 0.0001) and the estimation of percentage of emphysema measured in the lungs (ρ = 0.976; p < 0.0001), demonstrating the performance of the proposed method. The correlation coefficients are similar between the validation and test sets, showing a good generalization of the method to unseen data.
For BMD, the standard deviation of the agreement between the proposed network and the reference standard was σ = 15.97 HUs. Such σ is lower than the variability in HUs of normal, osteopenic and osteoporotic subjects, One limitation of the proposed method is the requirement of 2D fields of view of the structures where the biomarkers are computed. Ideally, one would like to regress on the whole CT scan, but it is currently unfeasible due to the limitations of current computational devices, at least at high resolutions. We have solved such issue using a standard object detector. Such object detection could be improved by using a deep learning method. Another limitation is that the CT scans acquired are non-contrast non-ECG gated thoracic CTs. It would be interesting to research how does this method perform when intravenous contrast is injected, augmenting the HUs in regions such as large vessels and the heart.
In this study we have used a very large database of subjects for training, validation and evaluation of the proposed method. A study on the dependance of the performance of the regression network based on the number of training cases used for training would be interesting, as well as to research if transfer learning could be used to learn one regressor from another one. Such tasks are left as future work.
The paradigm of image-to-biomarker directly may enable further research on large clinical datasets in other use cases. Several measurements are included in radiology reports, but the precise area of the image where they have been measured is rarely stored in the PACS systems. By leveraging a method that inputs radiology images and measurements, we could unlock such databases without the need of expensive expert annotations. We also believe that deep learning defines a holistic approach that exploits additional image content in the computation of the biomarkers beyond its established meaning, exploiting the systemic effect of many diseases, specially in chronic conditions.
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